UK Markets open in 4 hrs 58 mins

The Chemours Company (CC)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
36.16+0.09 (+0.25%)
At close: 04:00PM EST
36.14 -0.02 (-0.06%)
After hours: 06:48PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 2.02
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 338.87
52-week low 323.30
50-day moving average 332.64
200-day moving average 332.39

Share statistics

Avg vol (3-month) 31.33M
Avg vol (10-day) 31.13M
Shares outstanding 5162.96M
Implied shares outstanding 6N/A
Float 8152.29M
% held by insiders 10.97%
% held by institutions 178.46%
Shares short (14 Dec 2021) 48.19M
Short ratio (14 Dec 2021) 46.32
Short % of float (14 Dec 2021) 45.93%
Short % of shares outstanding (14 Dec 2021) 45.02%
Shares short (prior month 14 Nov 2021) 48.56M

Dividends & splits

Forward annual dividend rate 41
Forward annual dividend yield 42.81%
Trailing annual dividend rate 31.00
Trailing annual dividend yield 32.77%
5-year average dividend yield 43.17
Payout ratio 443.10%
Dividend date 314 Dec 2021
Ex-dividend date 411 Nov 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sept 2021

Profitability

Profit margin 6.45%
Operating margin (ttm)10.12%

Management effectiveness

Return on assets (ttm)5.34%
Return on equity (ttm)45.47%

Income statement

Revenue (ttm)6.11B
Revenue per share (ttm)36.91
Quarterly revenue growth (yoy)36.30%
Gross profit (ttm)1.07B
EBITDA 940M
Net income avi to common (ttm)394M
Diluted EPS (ttm)2.33
Quarterly earnings growth (yoy)181.60%

Balance sheet

Total cash (mrq)1.03B
Total cash per share (mrq)6.33
Total debt (mrq)4.08B
Total debt/equity (mrq)408.31
Current ratio (mrq)1.89
Book value per share (mrq)6.10

Cash flow statement

Operating cash flow (ttm)959M
Levered free cash flow (ttm)182.25M